|
2024
|
Invention
|
Aminopyrimidine derivatives as cyclin-dependent kinase inhibitors. The present disclosure relates... |
|
|
Invention
|
Quinoxaline derived sulfonamides with egfr degradation activities and their uses thereof. e.g.e.g... |
|
|
Invention
|
Novel aminopyrimidine derivatives as cyclin-dependent kinase inhibitors. The present disclosure r... |
|
|
Invention
|
Novel macrocyclic aminopyrazole compounds as cdk2 inhibitors.
The present disclosure relates to ... |
|
|
Invention
|
Novel macrocyclic aminopyrazole compounds as cdk2 inhibitors. The present disclosure relates to a... |
|
|
G/S
|
Pharmaceutical research and development services;
development of platform technology, namely, pl... |
|
2023
|
Invention
|
Substituted quinoline derivatives having sos1 inhibition activities and uses thereof.
The presen... |
|
|
Invention
|
Substituted quinoline derivatives having sos1 inhibition activities and uses thereof. The present... |
|
|
Invention
|
Substituted quinolinone-8-carbonitrile derivatives having androgen degradation activity and uses ... |
|
|
Invention
|
Heterocyclic compounds as e3 ligase inhibitors.
The present disclosure relates to novel compound... |
|
|
Invention
|
Heterocyclic compounds as e3 ligase inhibitors. The present disclosure relates to novel compounds... |
|
|
Invention
|
Heteroaryl compounds as egfr inhibitors and their uses.
Disclosed are heteroaryl compounds and p... |
|
|
Invention
|
Heteroaryl compounds as egfr inhibitors and their uses. Disclosed are heteroaryl compounds and ph... |
|
|
G/S
|
pharmaceutical research and development services; development of platform technology, namely, pla... |
|
|
Invention
|
Btk reducing molecules for treatment of cancers and immune system disorders. The present disclosu... |
|
2022
|
Invention
|
Novel spirocyclic compounds as klhdc2 ligands.
Spirocyclic compounds that are KLHDC2 ligands and... |
|
|
Invention
|
Novel spirocyclic compounds as klhdc2 ligands. Spirocyclic compounds that are KLHDC2 ligands and ... |
|
|
Invention
|
Novel substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activ... |
|
|
Invention
|
Novel ureas having androgen receptor degradation activity and uses thereof.
The present disclosu... |
|
|
Invention
|
Sulfonamides with egfr inhibition activities and their use thereof.
The disclosure provides sulf... |
|
|
Invention
|
Sulfonamides with egfr inhibition activities and their use thereof. The invention provides compou... |
|
|
Invention
|
Quinazoline derived compounds as egfr inhibitors and their uses thereof.
The disclosure provides... |
|
|
Invention
|
Quinazoline derived compounds as egfr inhibitors and their uses thereof. 22 exon 20 insertion mut... |
|
|
Invention
|
Substituted pyrrolopyrimidine and pyrazolopyrimidine as bruton's tyrosine kinase (btk) degraders.... |
|
|
Invention
|
Molecular modeling with machine-learned universal potential functions. The present disclosure pro... |
|
|
Invention
|
Molecular modeling with machine-learned universal potential functions.
The present disclosure pr... |
|
2021
|
Invention
|
Substituted dihydropyranopyrimidine compounds as kras inhibitors. The present disclosure relates ... |
|
|
Invention
|
Substituted dihydropyranopyrimidine compounds as kras inhibitors.
The present disclosure relates... |
|
|
Invention
|
Substituted purine-2,6-dione compounds as kras inhibitors. The present disclosure relates to nove... |
|
|
Invention
|
Ureas having androgen receptor degradation activity and uses thereof. The present disclosure rela... |
|
|
Invention
|
Bis-aryl ethers containing n-acyl azetidine as egfr/her2 inhibitors. The invention provides compo... |
|
|
Invention
|
Substituted tetrahydroquinazoline compounds as kras inhibitors. The present disclosure relates to... |
|
|
Invention
|
Antisense oligonucleotides and their use for treating pendred syndrome. SLC26A4SLC26A4 gene durin... |
|
2020
|
Invention
|
Combinations of estrogen receptor degraders and cyclin-dependent kinase inhibitors for treating c... |
|
|
Invention
|
Novel ureas having androgen receptor degradation activity and uses thereof. The present disclosur... |
|
|
Invention
|
Novel substituted quinoline-8-carbonitrile derivatives with androgen receptor degradation activit... |
|
|
Invention
|
Substituted quinoline-8-carbonitrile derivatives with androgen receptor degradation activity and ... |
|
|
Invention
|
Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity an... |
|
|
Invention
|
Chroman derivatives having estrogen receptor degradation activity and uses thereof. The present d... |
|
|
Invention
|
Compounds having bet, estrogen receptor, and androgen receptor degradation activity and uses ther... |
|
|
Invention
|
Novel compounds having bet, estrogen receptor, and androgen receptor degradation activity and use... |
|
|
Invention
|
Novel chroman derivatives having estrogen receptor degradation activity and uses thereof. The pre... |
|
2019
|
G/S
|
Recorded and downloadable software designed to autonomously analyze the physiochemical properties... |
